ACE2 and COVID-19: Furthermore, an in vivo study of SARS-CoV-2 infecting a human ACE2 transgenic mouse model in an animal biosafety level 3 (ABSL-3) laboratory will be able to confirm the potential of MG to act as a cell entry inhibitor as well as confirm the use of mulberry for the treatment of COVID-19 and, potentially, other diseases.